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KEYWORDS	
	 Three	 different	 spectrophotometric	 methods	 are	 developed	 for	 the	 determination	 of
naftidrofuryl	oxalate	(NAF)	in	pure	form	and	its	pharmaceutical	preparation.	The	methods	are
based	 on	 charge	 transfer	 complexation	 reactions	 of	 NAF	 as	 n‐electron	 donor	 with	 either
p‐chloranilic	 acid	 (PCA)	 or	 2,3‐dichloro‐5,6‐dicyano‐1,4‐benzoquinone	 (DDQ)	 or	 tetracyano
ethylene	 (TCNE)	 as	 π‐receptors	 to	 give	 highly	 colored	 anion	 radicals	 species.	 The	 colored
products	were	quantified	 spectrophotometrically	 at	515,	 588	and	396	nm	 in	PCA,	DDQ	and
TCNE	 methods,	 respectively.	 Under	 the	 optimized	 experimental	 conditions,	 Beer's	 law	 is
obeyed	over	the	concentration	ranges	of	75.0‐300.0,	25.0‐150.0	and	15.0‐	50.0	μg/mL	NAF	for
PCA,	DDQ	and	TCNE	methods,	respectively.	The	proposed	methods	were	applied	successfully
to	the	determination	of	NAF	in	pure	form	and	its	commercial	tablets	with	good	accuracy	and
precision.	 Statistical	 comparison	 of	 the	 results	was	 performed	 using	 Student's	 t‐test	 and	 F‐
ratio	 at	 95%	 confidence	 level,	 showing	 that	 there	 is	 no	 significant	 difference	 between	 the
reference	 and	 the	 proposed	 methods	 with	 regard	 to	 accuracy	 and	 precision.	 Further,	 the
validity	of	the	proposed	methods	was	confirmed	by	standard	addition	technique.	
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1.	Introduction	
	
Naftidrofuryl	 oxalate	 designated	 chemically	 as	 2‐(diethyl	
amino)	ethyl	2‐[(naphthalen‐1‐yl)	methyl]‐3‐(tetrahydrofuran‐
2‐yl)	propanoate	hydrogen	oxalate	 (Figure	1),	 is	 a	vasodilator	
drug	used	in	the	treatment	of	peripheral	and	cerebral	vascular	
disorders.	 It	 is	 claimed	 to	 enhance	 the	 cellular	 oxidative	
capacity	thereby	protecting	cells	against	ischemia	[1].	NAF	is	an	
official	 drug	 in	 the	 British	 Pharmacopoeia	 [2]	 where	 a	 non‐
aqueous	 potentiometric	 titration	 and	 HPLC	 procedures	 were	
described	 for	 the	 assay	 of	 NAF	 bulk	 powder	 and	 capsules,	
respectively.	
 
 
 
Figure	1.	Chemical	structure	of	naftidrofuryl	oxalate	(NAF).
 
Few	 analytical	 methods	 have	 been	 reported	 for	 the	
determination	 of	 NAF	 in	 biological	 fluids	 and/or	 pharma‐
ceutical	preparations.	Most	of	 these	 studies	 focused	on	HPLC‐
UV	 detection	 [3‐5],	 HPLC‐fluorescence	 detection	 [6,7]	 and	
phosphorimetric	analysis	[8,9]	Others	included	potentiometric	
methods	 using	 NAF	 ion‐selective	 electrodes	 [10,11]	 flow	
injection	 analysis	 with	 fluorescence	 opti‐sensor	 [12],	
spectrophotometric,	 spectrofluorimetric	 and	 voltammetric	
analyses	 in	 tablets	 [13],	 a	 spectrophotometric	 method	 using	
complexation	 reactions	 [14]	 and	 kinetic	 spectrophotometric	
method	 using	 alkaline	 potassium	 permanganate	 were	
described	[15].	Also	stability	indicating	methods	were	reported	
for	the	determination	of	the	drug	[16,17].	
To	 the	 best	 of	 our	 knowledge,	 only	 two	 visible	
spectrophotometric	 methods	 have	 been	 reported	 for	 the	
quantification	 of	 NAF	 in	 pharmaceuticals.	 Visible	 spectro‐
photometry,	 because	 of	 its	 simplicity	 and	 cost	 effectiveness,	
sensitivity	 and	 selectivity,	 fair	 accuracy,	 precision	 and	 easy	
access	 in	 most	 quality	 control	 laboratories,	 has	 remained	
competitive	 in	 an	 area	 of	 chromatographic	 techniques	 for	
pharmaceutical	 analysis.	 This	 paper	 describes,	 for	 the	 first	
time,	 the	 application	 of	 p‐chloranilic	 acid,	 2,3‐dichloro‐5,6‐
dicyano‐1,4‐benzoquinone	 and	 tetracyano	 ethylene	 as																
π‐acceptors	 to	 the	 spectrophotometric	 determination	 of	 NAF	
based	 on	 the	 interaction	 between	 these	 π‐acceptors	 and	 the	
oxygen	atom	of	tetrahydrofuran	ring	of	NAF	as	good	n‐electron	
donor	 to	 form	charge‐transfer	complexes.	The	purpose	of	 this	
investigation	was	directed	to	develop	simple,	sensitive,	precise	
and	 inexpensive	 procedures	 for	 the	 quantification	 of	 NAF	 in	
pharmaceutical	and	pure	form.	
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2.	Experimental	
	
2.1.	Apparatus	
	
All	absorption	spectra	and	derivatives	were	recorded	with	
a	 dual	 beam	 Shimadzu	 UV‐visible	 spectrophotometer	 1601PC	
with	 1	 cm	 quartz	 cuvettes,	 connected	 to	 an	 IBM	 compatible	
computer.	 The	 software	 was	 UVPC	 personal	 spectroscopy	
software	version	3.7	(Shimadzu),	Shimadzu	Corporation,	Kyoto,	
Japan.	
	
2.2.	Chemicals	and	reagents	
	
NAF	 was	 kindly	 supplied	 by	 Minapharm	 Pharmaceutical	
Industries	 Egypt.	 Its	 purity	 was	 found	 to	 be	 99.4±0.76,	
according	 to	 its	 official	 procedure	 [2].	 PRAXILENE®	 tablets	
(B.N.CCE0884)	 labeled	 to	 contain	 200	 mg	 NAF/tablet	 was	
purchased	 from	 the	 Egyptian	market.	 PCA	 (Rolex	 Laboratory	
Reagent,	Mumbai,	India):	0.125%	(w/v).	Solution	in	acetonitrile	
(Merck,	 Mumbai,	 India)	 was	 prepared	 and	 kept	 in	 the	 dark	
when	 not	 in	 use.	 DDQ	 (Avra	 Synthesis	 Pvt.	 Ltd.,	 Hyderabad,	
India):	 0.2%	 (w/v)	 solution	 in	 acetonitrile	 (Merck,	 Mumbai,	
India),	 was	 prepared	 fresh	 just	 before	 use.	 TCNE	 (Sd.	 Fine	
Chem.	 India	 Ltd.):	 0.2%	 (w/v)	 solution	 in	 acetonitrile	 (Merck,	
Mumbai,	 India),	 was	 prepared	 fresh	 just	 before	 use.	 All	
chemicals	and	reagents	were	of	analytical	reagent	grade.	
	
2.3.	Standard	solutions	
	
Naftidrofuryl	oxalate	(NAF)	stock	solution	0.5	mg/mL	was	
prepared	in	acetonitrile.	
	
3.	Procedures	
	
3.1.	Construction	of	calibration	curves	
	
3.1.1.	Method	A	(PCA)	
	
Different	 aliquots	 (1.50,	 2.00,	 …,	 6.00	 mL)	 of	 a	 standard	
NAF	 (0.5	mg/mL)	 solution	were	 accurately	 transferred	 into	 a	
series	of	10	mL	volumetric	flasks	followed	by	2.5	mL	of	0.125%	
PCA	 solution.	 The	 content	 was	 mixed	 well,	 diluted	 to	 the	
volume	with	acetonitrile	and	the	absorbance	was	measured	at	
515	 nm	 against	 a	 reagent	 blank	 prepared	 simultaneously.	 A	
calibration	curve	was	constructed	and	the	regression	equation	
was	computed.	
	
3.1.2.	Method	B	(DDQ)	
	
Different	 aliquots	 (0.50,	 1.00,	 …,	 3.00	 mL)	 of	 a	 standard	
NAF	 (0.5	mg/mL)	 solution	were	 accurately	 transferred	 into	 a	
series	of	10	mL	volumetric	 flasks	 followed	by	3.0	mL	of	0.2%	
DDQ	 solution.	 The	 content	was	mixed	well,	 kept	 aside	 for	 15	
minutes.	 Then	 diluted	 to	 the	 volume	 with	 acetonitrile.	 The	
absorbance	was	measured	 at	 588	nm	against	 a	 reagent	 blank	
prepared	simultaneously.	A	 calibration	 curve	was	constructed	
and	the	regression	equation	was	computed.	
	
3.1.3.	Method	C	(TCNE)	
	
Different	 aliquots	 (0.30,	 0.40,	 …,	 1.00	 mL)	 of	 a	 standard	
NAF	 (0.5	mg/mL)	 solution	were	 accurately	 transferred	 into	 a	
series	of	10	mL	volumetric	 flasks	 followed	by	1.0	mL	of	0.2%	
TCNE	solution.	The	content	was	mixed	well	and	kept	aside	for	
25	 minutes.	 The	 mixture	 was	 diluted	 to	 the	 volume	 with	
acetonitrile.	The	absorbance	was	measured	at	396	nm	against	a	
reagent	 blank	 prepared	 simultaneously.	 A	 calibration	 curve	
was	constructed	and	the	regression	equation	was	computed.	
	
	
	
3.2.	Application	to	pharmaceutical	preparation	
	
Ten	 tablets	 of	 "PRAXILANE"	 each	 containing	 200	mg	NAF	
were	 weighed	 and	 finely	 powdered.	 An	 accurately	 weighed	
amount	 of	 the	 powder	 equivalent	 to	 50.0	 mg	 of	 NAF	 was	
dissolved	 in	 about	 25	 mL	 of	 acetonitrile	 by	 shaking	 in	
ultrasonic	 bath	 for	 1	 hr.	 The	 solution	 was	 filtered	 and	
transferred	 quantitatively	 into	 100	 mL	 volumetric	 flask.	 The	
volume	was	then	completed	to	the	mark	with	acetonitrile.	The	
necessary	 dilutions	 were	 made	 to	 reach	 concentrations	 of	
linear	 range.	 The	 procedures	 described	 under	 construction	 of	
calibration	 curves	 for	 the	 proposed	 methods	 were	 then	
followed	 and	 the	 concentration	 of	 NAF	was	 determined	 from	
the	corresponding	regression	equation.	
	
3.3.	Stoichiometric	relationship	
	
Job's	 method	 of	 continuous	 variations	 of	 equimolar	
solutions	was	 employed	 to	 establish	 the	 stoichiometry	 of	 the	
formed	 complexes.	 The	 solutions	 equivalent	 to	 1.00×10‐2,	
5.00×10‐3	 and	 5.00×10‐4	M	NAF	 and	 similar	 concentrations	 of	
PCA,	 DDQ	 and	 TCNE	were	 prepared,	 respectively.	 A	 series	 of	
solutions	was	prepared	 in	which	 the	 total	volume	of	NAF	and	
reagent	 was	 kept	 at	 10	 mL.	 The	 solutions	 were	 mixed	 in	
various	proportions;	in	method	A,	the	volume	was	completed	to	
the	mark	 immediately	with	acetonitrile	while	 the	volume	was	
completed	to	the	mark	after	15	and	25	min	with	acetonitrile	in	
case	 of	 method	 B	 and	 C,	 respectively.	 The	 absorbance	 of	 the	
resulting	 solutions	 was	 measured	 at	 the	 respective	
wavelengths	of	maximum	absorbance	(λmax)	against	the	reagent	
blank.		
	
4.	Results	and	discussion	
	
The	 reaction	of	‐acceptors	with	NAF	 as	n‐electron	donor	
results	 in	 the	 formation	 of	 an	 intense	 orange‐red	 product,	
which	exhibits	absorption	maximum	at	515	nm	in	case	of	PCA	
(Figure	 2)	 due	 to	 the	 formation	 of	 the	 corresponding	 PCA	
radical	anion.	Intense	reddish	violet	color	was	appeared	which	
exhibits	absorption	maxima	at	588,	545	and	455	nm	in	case	of	
DDQ	 (Figure	 3).	 For	 NAF‐DDQ	 charge	 transfer	 complex	 the	
absorption	 band	 at	 588	 nm	 was	 selected	 as	 analytical	
wavelength	 keeping	 in	 view	 the	 sensitivity	 of	 the	 reaction	
product	and	blank	absorbance.	Intense	yellow	colored	product	
was	 developed	 which	 exhibits	 absorption	 maximum	 at	 396,	
414	 nm	 in	 case	 of	 TCNE	 (Figure	 4).	 For	 NAF‐TCNE	 charge	
transfer	complex	the	absorption	band	at	396	nm	was	selected	
as	analytical	wavelength	keeping	 in	view	the	sensitivity	of	 the	
reaction	product.	
	
	
Figure	2.	Absorption	spectra	of	NAF,	25.0	μg/mL,	that	of	its	charge	transfer	
complex	with	PCA,	200.0	μg/mL,	and	reagent	blank	in	acetonitrile.		
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Figure	3.	Absorption	spectra	of	NAF,	50.0	μg/mL,	that	of	its	charge	transfer	
complex	with	DDQ,	100.0	μg/mL	and	reagent	blank	in	acetonitrile.	
	
	
	
	
Figure	 4.	 Absorption	 spectra	 of	 NAF,	 25.0	 μg/mL,	 and	 that	 of	 its	 charge	
transfer	complex	with	TCNE,	50.0	μg/mL	and	reagent	blank in	acetonitrile.
	
The	effect	of	 the	reagent	concentration	on	 the	 intensity	of	
the	 color	 developed	 at	 the	 selected	 wavelengths	 was	
ascertained	 by	 adding	 different	 amounts	 of	 the	 reagents	 PCA,	
DDQ	and	TCNE	to	a	fixed	concentration	of	200.0	μg/mL	NAF	in	
method	 A,	 100	 μg/mL	 in	 method	 B	 and	 50.0	 μg/mL	 NAF	 in	
method	 C.	 It	 was	 found	 that	 2	mL	 of	 0.125%	 PCA,	 3.0	mL	 of	
0.2%	DDQ	and	1.0	mL	of	0.2%	TCNE	solutions	were	sufficient	
for	 the	 production	 of	 maximum	 and	 reproducible	 color	
intensity	 and	 the	 highest	 absorbance	 remained	 unaffected	 by	
further	addition	of	these	reagents	(Figure	5).	
	
	
Figure	5.	Effect	 of	 PCA	 (0.125%,	w/v),	 DDQ	 (0.2%,	w/v)	 and	 TCNE	 (0.2%,	
w/v)	volumes	on	the	absorbance	of	the	colored	complexes.	
	
	
In	 order	 to	 select	 the	 suitable	 solvent	 for	 charge	 transfer	
complex	 formation,	 the	 reaction	 of	 NAF	 with	 PCA,	 DDQ	 and	
TCNE	was	carried	out	in	different	solvents	such	as	chloroform,	
acetone,	 methanol	 and	 acetonitrile.	 Acetonitrile	 was	 found	 to	
be	optimum	because	it	afforded	the	maximum	sensitivity	when	
compared	with	all	 other	 solvents	 and	 it	possesses	 the	highest	
dielectric	 constant	 of	 all	 solvents	 examined	 (Figure	 6),	 a	
property	 which	 is	 known	 to	 promote	 the	 dissociation	 of	 the	
original	charge‐transfer	complexes	to	the	radical	anions.	
	
	
Figure	6.	Effect	of	solvent	type	on	the	absorbance	of	the	colored	complexes	
formed	 between	 100	 µg/mL	NAF	with	0.2%	DDQ	and	0.125%	PCA	 and	 50	
µg/mL	NAF	with	0.2%TCNE.	
	
The	 optimum	 reaction	 time	was	 determined	 by	 following	
the	color	development	upon	the	addition	of	reagent	solution	to	
the	 NAF	 solution	 at	 room	 temperature.	 Complete	 color	
development	was	attained	after	15	and	20	min	with	DDQ	and	
TCNE,	respectively,	(Figure	7)	while	the	reaction	with	PCA	was	
instantaneous.	 The	 absorbance	 of	 these	 radical	 anions	
remained	stable	for	at	least	60	min.	
	
	
Figure	7.	Effect	of	reaction	time	on	the	absorbance	of	the	colored	complexes	
formed	 between	 100	 µg/mL	NAF	with	0.2%	DDQ	and	0.125%	PCA	 and	 40	
µg/mL	NAF	with	0.2%TCNE.
	
Job's	continuous	variations	graph	for	the	reaction	between	
NAF	 and	 PCA	 or	 DDQ	 or	 TCNE	 shows	 that	 the	 interaction	
occurs	 on	 an	 equimolar	 basis	 via	 the	 formation	 of	 a	 charge‐
transfer	 complexes	 1:1	 (NAF:Reagent)	 (Figure	 8)	 This	 finding	
was	 anticipated	 by	 the	 presence	 of	 one	 basic	 or	 electron	
donating	center	(‐O‐)	in	tetrahydrofuran	ring	of	NAF.	
Under	optimum	experimental	conditions	for	determination	
of	 the	drug	under	 study,	 the	absorbance	versus	concentration	
plots	were	found	to	be	linear	over	the	concentration	ranges	of	
75.0‐300.0,	25.0‐150.0	and	15.0‐50.0	μg/mL	in	the	case	of	PCA,	
DDQ	and	TCNE,	respectively,	(Figure	9).	
	
	
Younes	et	al.	/	European	Journal	of	Chemistry	5	(2)	(2014)	272‐276	 275	
 
	
Table	1.	Assay	validation	sheet	for	the	proposed	spectrophotometric	methods	for	the	analysis	of	naftidrofuryl	oxalate.	
Parameters Naftidrofuryl	Oxalate
PCA	 DDQ TCNE	
Range	(µg/mL)	 75.0‐300.0	 25.0‐150.0 15.0‐50.0	
Regression	equation	 	
Slope	 0.0025	 0.0047 0.0192	
Intercept	 0.0104	 0.2138 ‐0.1169	
Correlation	coefficient	(r)	 0.9994	 0.9996 0.9994	
Accuracy	 99.36±0.87	 99.78±1.35 100.78±1.83	
LOD	(µg/mL)	 10.50	 5.57	 5.40	
LOQ	(µg/mL)	 11.5	 19.7	 18.4	
Repeatability	a	 1.400	 1.537	 1.940	
Intermediate	precision	*	 1.650	 1.368 1.815	
a	Intra‐day	(n	=	3)	relative	standard	deviations	of	samples	of	concentrations	(100,	150.0,	200.0	μg/mL),	(50.0,	100.0,	150.0	μg/mL)	and	(20.0,	40.0,	50.0	μg/mL)	
for	PC‐A,	DDQ	and	TCNE	methods,	respectively	of	naftidrofuryl	oxalate	by	colorimetric	methods.	
b	Inter‐day	(n	=	3)	relative	standard	deviations	of	samples	of	concentrations	(100.0,	150.0	μg/mL),	(50.0,	100.0	μg/mL)	and	(40.0,	50.0	μg/mL)	for	PC‐A,	DDQ	and	
TCNE	methods	respectively	of	naftidrofuryl	oxalate	by	colorimetric	methods.	
	
	
Table	2.	Analysis	of	naftidrofuryl	oxalate	 in	pharmaceutical	preparation	by	 the	proposed	PCA,	DDQ	and	TCNE	methods	and	application	of	standard	addition	
technique.	
Dosage	form	 Found	(%)	*	 Added	standard	(μg/mL)	 Found	(μg/mL)	*	 Recovery	(%)	of	added	standard	
Praxilene	®	200	mg	tablets		
(batch	no.	CCE0884)	
99.71±0.14	
(PCA	method)	
75.0 75.81 101.08	
100.0 101.17 101.17	
100.0 98.37 98.37	
Mean±S.D	 	 100.21±1.59	
Praxilene	®	200	mg	tablets		
(batch	no.	CCE0884) 
102.87±1.06	
(DDQ	method) 
25.0	 24.42	 97.68	
50.0 50.54 101.08	
75.0 74.54 99.38	
Mean±S.D	 	 99.38±1.7	
Praxilene	®	200	mg	tablets		
(batch	no.	CCE0884)	
101.55±0.66	
(TCNE	method) 
15.0 15.10 100.69	
20.0	 19.73	 98.65	
25.0 24.99 99.94	
Mean±S.D	 	 99.76±1.03 
*	Average	of	three	determinations.	
 
	
	
Figure	 8.	 Determination	 of	 the	 stoichiometry	 of	 the	 reaction	 between	
(1.00×10‐2	 M)	 PCA,	 (5.00×1‐3	 M)	 DDQ,	 (5.00×10‐4	 M)	 TCNE	 and	 the	
corresponding	concentrations	of	NAF	by	continuous	variation	method.	
	
	
Figure	 9.	 Linearity	 of	 the	 absorbance	 of	 the	 colored	 PCA	 complex,	 DDQ
complex	 and	 TCNE	 complex	 to	 the	 corresponding concentration	 of	 NAF	
(µg/mL).	
The	regression	equations	were	computed	and	found	to	be:	
	
A	=	0.0025	C	+	0.0104	r	=	0.9994	(for	PCA	(method	A)	 (1)	
	
A	=	0.0047	C	+	0.2138	r	=	0.9996	(for	DDQ	(method	B)	 (2)	
	
A	=	0.0192	C	‐	0.1169	r	=	0.9994	(for	TCNE	(method	C)	 (3)	
	
where	A	 is	 the	absorbance	at	515,	588	and	396	nm	 in	case	of	
PCA,	DDQ	and	TCNE,	respectively,	C	is	the	concentration	of	NAF	
in	μg/mL	and	r	is	the	correlation	coefficient.	
The	regression	parameters	calculated	 from	the	calibration	
graphs	 data,	 along	 with	 the	 standard	 deviations	 of	 the	 slope	
(Sb)	and	the	intercept	(Sa)	showed	good	results.	The	linearity	of	
the	calibration	graphs	was	demonstrated	by	the	high	values	of	
the	correlation	coefficients	(r)	(Table	1).	Where	the	accuracy	of	
the	 proposed	methods	was	 checked	 by	 under	 construction	 of	
calibration	 curves	 were	 repeated	 for	 the	 determination	 of	
different	 concentrations	 of	 NAF.	 The	 concentrations	 were	
calculated	 from	 the	 corresponding	 regression	 equations.	 The	
sensitivity	 of	 proposed	methods	was	 checked	 by	 through	 the	
limit	of	detection	(LOD)	and	 limit	of	quantification	(LOQ).	The	
LOD	 and	 LOQ	 are	 calculated	 and	 recorded	 for	 the	 proposed	
methods	in	(Table	1).	
In	 order	 to	 determine	 the	 precision	 of	 the	 proposed	
methods,	solutions	containing	three	different	concentrations	of	
NAF	were	 prepared	 and	 analyzed	 in	 three	 replicates	 and	 the	
analytical	results	are	summarized	in	(Table	1).	The	low	values	
of	 the	 relative	 standard	 deviation	 (%	R.S.D)	 indicate	 the	 high	
precision	and	the	good	accuracy	of	the	proposed	methods.	RSD	
(%)	 values	 were	 obtained	 within	 the	 same	 day	 to	 evaluate	
repeatability	 (intra‐day	 precision)	 and	 over	 three	 days	 to	
evaluate	intermediate	precision	(inter‐day	precision).	
The	 proposed	 methods	 were	 successfully	 applied	 to	 the	
determination	 of	 NAF	 in	 the	 representative	 tablets	 Praxilene	
200	mg.	The	results	obtained	are	showed	in	(Table	2)	and	were	
compared	 with	 those	 obtained	 by	 the	 official	 method	 [2]	 by	
means	of	Student's	t‐	and	F‐tests	at	95%	confidence	level.		
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Table	3.	Statistical	comparison	for	the	results	obtained	by	the	proposed	methods	and	the	official	one	for	the	analysis	of	NAF	in	pure	powder	form.		
Item	 PCA	method	 DDQ	method TCNE	method Official	method		**	
Mean	 99.31	 99.78 100.78 99.66	
S.D.	 0.87	 1.35	 1.83	 1.62	
Variance.	 0.75	 1.82	 3.34	 2.62	
N	 6	 6	 6	 6	
F	[5.05]	*	 3.49	 1.44 1.27
t	[2.23]	*	 0.47	 0.139 1.128
*	The	figures	in	parenthesis	are	the	corresponding	tabulated	values	at	p	=	0.05.		
**	Potentiometric	titration	with	acetous	perchloric	acid	in	non‐aqueous	titration.		
	
	
Table	4.	Analysis	of	naftidrofuryl	oxalate	in	the	presence	of	common	excepients	by	the	proposed	spectrophotometric	methods.	
Ingredient	 Recovery	%	±	RSD	*	
PCA	method DDQ	method TCNE	method	
Na	alginate  98.7±3.90	 101.2±1.20	 99.9±0.52	
Talc	 99.7±1.30	 100.0±0.09	 98.2±0.33	
Mg	stearate 	 100.4±1.38 100.5±0.78 101.4±1.60	
Ca	gluconate	 101.5±1.89 100.2±0.69 101.5±1.19	
Lactose	 99.0±3.11 100.4±1.36 100.6±0.61	
Starch	 100.1±0.15 100.3±1.07 98.5±1.11	
Glucose	 100.3±1.54 100.4±0.55 100.3±1.07	
*Average	of	three	determinations.	
	
	
The	 values	 of	 the	 calculated	 t	 and	 F	 are	 less	 than	 the	
tabulated	 ones,	 which	 reveals	 that	 there	 is	 no	 significant	
difference	with	respect	to	accuracy	and	precision	between	the	
proposed	methods	and	the	official	one	(Table	3).	
The	 selectivity	 of	 proposed	methods	 was	 checked	 by	 the	
effect	 of	 the	 presence	 of	 common	 excipients,	 such	 as	 talc,	
starch,	lactose,	glucose,	sodium	alginate,	calcium	gluconate	and	
magnesium	stearate	was	tested	for	possible	interference	in	the	
assay	by	placebo	blank	and	synthetic	mixture	analyses	whereas	
no	significant	interference	was	observed	from	these	excipients	
as	shown	in	Table	4.	
 
5.	Conclusion	
	
The	 proposed	 methods	 in	 this	 study	 are	 based	 on	 well‐
characterized	charge‐transfer	complexation	reaction,	and	have	
the	advantages	of	simplicity,	speed,	accuracy	and	precision,	and	
use	of	 inexpensive	equipment	compared	to	the	reported	HPLC	
and	 electrochemical	 methods.	 The	 TCNE	 method	 is	 more	
sensitive	 than	 the	 PCA	 and	 DDQ	 methods	 as	 seen	 from	 the	
lower	 LOD	 value.	 The	 highlight	 of	 the	 proposed	 methods	 is	
their	ability	to	quantify	naftidrofuryl	oxalate	in	pharmaceutical	
formulation	 without	 any	 interference	 from	 the	 common	
excipients.	Thus,	the	methods	are	useful	for	the	quality	control	
and	routine	analysis	of	NAF	in	pharmaceutical	and	commercial	
formulation.	
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